# EDGAR Filing Document

**Accession Number:** 0000860730
**File Stem:** 0001193125-26-187155
**Filing Date:** 2026-4
**Character Count:** 7074
**Document Hash:** d16c69d945699ab048494321e73c706d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-187155.hdr.sgml**: 20260428

**ACCESSION NUMBER**: 0001193125-26-187155

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 11

**CONFORMED PERIOD OF REPORT**: 20260423

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**FILED AS OF DATE**: 20260428

**DATE AS OF CHANGE**: 20260428

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** HCA Healthcare, Inc.
- **CENTRAL INDEX KEY:** 0000860730
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 273865930
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-11239
- **FILM NUMBER:** 26908170

**BUSINESS ADDRESS:**
- **STREET 1:** ONE PARK PLZ
- **CITY:** NASHVILLE
- **STATE:** TN
- **ZIP:** 37203
- **BUSINESS PHONE:** 6153449551

**MAIL ADDRESS:**
- **STREET 1:** ONE PARK PLAZA
- **CITY:** NASHVILLE
- **STATE:** TN
- **ZIP:** 37203

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HCA Holdings, Inc.
- **DATE OF NAME CHANGE:** 20101126

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HCA INC/TN
- **DATE OF NAME CHANGE:** 20010627

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HCA THE HEALTHCARE CO
- **DATE OF NAME CHANGE:** 20010419

?xml version='1.0' encoding='ASCII'? 8-K

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION

#### Washington, D.C. 20549

### FORM 8-K

#### CURRENT REPORT

#### PURSUANT TO SECTION 13 OR 15(d)

#### OF THE SECURITIES EXCHANGE ACT OF 1934

#### Date of Report (Date of earliest event reported): April 28, 2026 (April 23, 2026)

## HCA HEALTHCARE, INC.

#### (Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-11239** | **27-3865930** |
| **(State or other jurisdiction**<br> **of incorporation)** | **(Commission**<br> **File Number)** | **(IRS Employer**<br> **Identification No.)** |

---

---

| | |
|:---|:---|
| **One Park Plaza, Nashville, Tennessee** | **37203** |
| **(Address of principal executive offices)** | **(Zip Code)** |

---

#### Registrant's telephone number, including area code: (615) 344-9551

#### Not Applicable

#### (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | |
|:---|:---|
| **Title of each class** | **Name of each exchange**<br> **on which registered** |
| Common Stock, $.01 par value per share HCA | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

---

| | |
|:---|:---|
| **Item 5.07.** | **Submission of Matters to a Vote of Security Holders.**  |

---

HCA Healthcare, Inc. (the "Company") held its Annual Meeting of Stockholders (the "Annual Meeting") on April 23, 2026. At the Annual Meeting, a total of 209,777,472 shares of the Company's common stock, out of a total of 223,568,966 shares of common stock outstanding and entitled to vote as of the record date for the Annual Meeting, were represented in person or by proxy. Voting results from the Annual Meeting were as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. The following nine director nominees were elected to the Company's Board of Directors for a one-year term, or until such director's respective successor is duly elected and qualified or until such director's earlier death, resignation or removal, as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | For | Against | Abstentions | Broker Non-Votes |
|  Thomas F. Frist III | 187441344 | 7941596 | 51198 | 14343334 |
|  Samuel N. Hazen | 193666243 | 1713185 | 54710 | 14343334 |
|  John W. Chidsey, III | 193625050 | 1749879 | 59209 | 14343334 |
|  Nancy-Ann DeParle | 173121216 | 22234733 | 78189 | 14343334 |
|  William R. Frist | 191413785 | 3970200 | 50153 | 14343334 |
|  Hugh F. Johnston | 179518581 | 15858336 | 57221 | 14343334 |
|  Michael W. Michelson | 188824111 | 6553509 | 56518 | 14343334 |
|  Wayne J. Riley, M.D. | 186133512 | 9085173 | 215453 | 14343334 |
|  Andrea B. Smith | 189234726 | 6136191 | 63221 | 14343334 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026 was ratified as follows:

---

| | | | |
|:---|:---|:---|:---|
| For | Against | Abstentions | Broker Non-Votes |
| 192731533 | 16987639 | 58300 | 0 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. The adoption of a non-binding advisory resolution on the Company's named executive officer compensation as described in the Company's 2026 proxy statement was approved as follows:

---

| | | | |
|:---|:---|:---|:---|
| For | Against | Abstentions | Broker Non-Votes |
| 182386619 | 12758446 | 289073 | 14343334 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. The stockholder proposal regarding a report on healthcare consequences as described in the Proxy Statement was not approved as follows:

---

| | | | |
|:---|:---|:---|:---|
| For | Against | Abstentions | Broker Non-Votes |
| 21156498 | 173337098 | 940542 | 14343334 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. The stockholder proposal regarding shareholders' right to act by written consent as described in the Proxy Statement was not approved as follows:

---

| | | | |
|:---|:---|:---|:---|
| For | Against | Abstentions | Broker Non-Votes |
| 42842519 | 152097860 | 493759 | 14343334 |

---

------

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| HCA HEALTHCARE, INC. | HCA HEALTHCARE, INC. |
| By: | /s/ John M. Franck II |
|  | John M. Franck II |
|  | Vice President – Legal and Corporate Secretary |

---

Date: April 28, 2026